The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Kidney Transplantation

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Kidney Transplantation


Psychiatry related information on Kidney Transplantation


High impact information on Kidney Transplantation


Chemical compound and disease context of Kidney Transplantation


Biological context of Kidney Transplantation


Anatomical context of Kidney Transplantation


Associations of Kidney Transplantation with chemical compounds


Gene context of Kidney Transplantation


Analytical, diagnostic and therapeutic context of Kidney Transplantation


  1. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. Lowance, D., Neumayer, H.H., Legendre, C.M., Squifflet, J.P., Kovarik, J., Brennan, P.J., Norman, D., Mendez, R., Keating, M.R., Coggon, G.L., Crisp, A., Lee, I.C. N. Engl. J. Med. (1999) [Pubmed]
  2. Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. Bakris, G.L., Sauter, E.R., Hussey, J.L., Fisher, J.W., Gaber, A.O., Winsett, R. N. Engl. J. Med. (1990) [Pubmed]
  3. Captopril in hypertension after renal transplantation. Herlitz, H., Ahlmen, J., Aurell, M., Blohmé, I., Brynger, H., Delin, K., Larsson, O. Lancet (1983) [Pubmed]
  4. Recurrence of nephrotic syndrome during cyclosporin treatment after renal transplantation. Voets, A.J., Hoitsma, A.J., Koene, R.A. Lancet (1986) [Pubmed]
  5. Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation. Chen, C.H., Chen, P.J., Chu, J.S., Yeh, K.H., Lai, M.Y., Chen, D.S. Gastroenterology (1994) [Pubmed]
  6. Compliance and late acute rejection after kidney transplantation: a psycho-medical perspective. Baines, L.S., Joseph, J.T., Jindal, R.M. Clinical transplantation. (2002) [Pubmed]
  7. Relationship between urinary concentrating ability, arginine vasopressin in plasma and blood pressure after renal transplantation. Pedersen, E.B., Danielsen, H., Nielsen, A.H., Knudsen, F., Jensen, T., Kornerup, H.J., Madsen, M. Scand. J. Clin. Lab. Invest. (1985) [Pubmed]
  8. Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation. Christ, B., Brockmeier, D., Hauck, E.W., Friemann, S. Urology (2001) [Pubmed]
  9. Improved graft survival after renal transplantation in the United States, 1988 to 1996. Hariharan, S., Johnson, C.P., Bresnahan, B.A., Taranto, S.E., McIntosh, M.J., Stablein, D. N. Engl. J. Med. (2000) [Pubmed]
  10. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. Vincenti, F., Kirkman, R., Light, S., Bumgardner, G., Pescovitz, M., Halloran, P., Neylan, J., Wilkinson, A., Ekberg, H., Gaston, R., Backman, L., Burdick, J. N. Engl. J. Med. (1998) [Pubmed]
  11. Renal transplantation in children. A report of the North American Pediatric Renal Transplant Cooperative Study. McEnery, P.T., Stablein, D.M., Arbus, G., Tejani, A. N. Engl. J. Med. (1992) [Pubmed]
  12. Advanced glycosylation end products in patients with diabetic nephropathy. Makita, Z., Radoff, S., Rayfield, E.J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E.A., Cerami, A., Vlassara, H. N. Engl. J. Med. (1991) [Pubmed]
  13. Acyclovir for life-threatening herpes simplex virus infection after renal transplantation. Heaton, A., Arze, R.S., Ward, M.K. Lancet (1981) [Pubmed]
  14. Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy. Read, A.E., Wiesner, R.H., LaBrecque, D.R., Tifft, J.G., Mullen, K.D., Sheer, R.L., Petrelli, M., Ricanati, E.S., McCullough, A.J. Ann. Intern. Med. (1986) [Pubmed]
  15. Effects of enalapril on erythrocytosis after renal transplantation. Gaston, R.S., Julian, B.A., Diethelm, A.G., Curtis, J.J. Ann. Intern. Med. (1991) [Pubmed]
  16. Hyperuricemia after kidney transplantation in patients treated with cyclosporine. Marcen, R., Gallego, N., Gamez, C., Orofino, L., Ortuño, J. Am. J. Med. (1992) [Pubmed]
  17. Normalization of hepatic glucose regulation despite systemic insulin delivery. Studies in patients with pancreatic transplantation for type 1 (insulin-dependent) diabetes mellitus. Wilczek, H., Gunnarsson, R., Felig, P., Ostman, J., Groth, C.G., Wahren, J. Diabetologia (1991) [Pubmed]
  18. Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. Nesbitt, T., Coffman, T.M., Griffiths, R., Drezner, M.K. J. Clin. Invest. (1992) [Pubmed]
  19. Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Hollander, A.A., van Saase, J.L., Kootte, A.M., van Dorp, W.T., van Bockel, H.J., van Es, L.A., van der Woude, F.J. Lancet (1995) [Pubmed]
  20. Kinetics of serum and urinary aluminium after renal transplantation. Boukari, M., Jaudon, M.C., Rottembourg, P.F., Luciani, J., Legrain, M., Galli, A. Lancet (1978) [Pubmed]
  21. The cost effectiveness of mycophenolate mofetil in the first year after primary cadaveric transplant. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Sullivan, S.D., Garrison, L.P., Best, J.H. J. Am. Soc. Nephrol. (1997) [Pubmed]
  22. Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. White, C., Akbari, A., Hussain, N., Dinh, L., Filler, G., Lepage, N., Knoll, G.A. J. Am. Soc. Nephrol. (2005) [Pubmed]
  23. Erythrocyte choline uptake after renal transplantation. Poli de Figueiredo, C.E., Ellory, J.C., Hendry, B.M. Lancet (1992) [Pubmed]
  24. Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Bohman, S.O., Tydén, G., Wilczek, H., Lundgren, G., Jaremko, G., Gunnarsson, R., Ostman, J., Groth, C.G. Diabetes (1985) [Pubmed]
  25. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. Heeger, P.S., Greenspan, N.S., Kuhlenschmidt, S., Dejelo, C., Hricik, D.E., Schulak, J.A., Tary-Lehmann, M. J. Immunol. (1999) [Pubmed]
  26. Evidence for free radical formation during human kidney transplantation. Pincemail, J., Defraigne, J.O., Franssen, C., Bonnet, P., Deby-Dupont, G., Pirenne, J., Deby, C., Lamy, M., Limet, M., Meurisse, M. Free Radic. Biol. Med. (1993) [Pubmed]
  27. Cyclosporine in cadaveric renal transplantation. Evans, R.W. N. Engl. J. Med. (1984) [Pubmed]
  28. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. Hall, B.M., Tiller, D.J., Hardie, I., Mahony, J., Mathew, T., Thatcher, G., Miach, P., Thomson, N., Sheil, A.G. N. Engl. J. Med. (1988) [Pubmed]
  29. Clonazepam in the treatment of steroid-induced mania in a patient after renal transplantation. Viswanathan, R., Glickman, L. N. Engl. J. Med. (1989) [Pubmed]
  30. Ineffectiveness of ascorbic acid therapy in nephropathic cystinosis. Schneider, J.A., Schlesselman, J.J., Mendoza, S.A., Orloff, S., Thoene, J.G., Kroll, W.A., Godfrey, A.D., Schulman, J.D. N. Engl. J. Med. (1979) [Pubmed]
  31. Benefits of HLA-A and HLA-B matching on graft and patient outcome after cadaveric-donor renal transplantation. Sanfilippo, F., Vaughn, W.K., Spees, E.K., Light, J.A., LeFor, W.M. N. Engl. J. Med. (1984) [Pubmed]
  32. Effect of HLA-A and HLA-B matching on survival of grafts and recipients after renal transplantation. Persijn, G.G., Cohen, B., Lansbergen, Q., D'Amaro, J., Selwood, N., Wing, A., van Rood, J.J. N. Engl. J. Med. (1982) [Pubmed]
  33. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. Ruf, R.G., Lichtenberger, A., Karle, S.M., Haas, J.P., Anacleto, F.E., Schultheiss, M., Zalewski, I., Imm, A., Ruf, E.M., Mucha, B., Bagga, A., Neuhaus, T., Fuchshuber, A., Bakkaloglu, A., Hildebrandt, F. J. Am. Soc. Nephrol. (2004) [Pubmed]
  34. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation. Hokken-Koelega, A.C., Stijnen, T., de Muinck Keizer-Schrama, S.M., Blum, W.F., Drop, S.L. J. Clin. Endocrinol. Metab. (1993) [Pubmed]
  35. Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect. Härtel, C., Schumacher, N., Fricke, L., Ebel, B., Kirchner, H., Müller-Steinhardt, M. Clin. Chem. (2004) [Pubmed]
  36. Steroid-free immunosuppression in renal transplantation. Birkeland, S.A. Lancet (1996) [Pubmed]
  37. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Margreiter, R. Lancet (2002) [Pubmed]
  38. Renal transplantation after removal and prevention of resynthesis of HLA antibodies. Taube, D.H., Williams, D.G., Cameron, J.S., Bewick, M., Ogg, C.S., Rudge, C.J., Welsh, K.I., Kennedy, L.A., Thick, M.G. Lancet (1984) [Pubmed]
  39. Prevention of prednisone-induced negative nitrogen balance. Effect of dietary modification on urea generation rate in patients on hemodialysis receiving high-dose glucocorticoids. Cogan, M.G., Sargent, J.A., Yarbrough, S.G., Vincenti, F., Amend, W.J. Ann. Intern. Med. (1981) [Pubmed]
  40. Renal amyloidosis with a frame shift mutation in fibrinogen aalpha-chain gene producing a novel amyloid protein. Hamidi Asl, L., Liepnieks, J.J., Uemichi, T., Rebibou, J.M., Justrabo, E., Droz, D., Mousson, C., Chalopin, J.M., Benson, M.D., Delpech, M., Grateau, G. Blood (1997) [Pubmed]
WikiGenes - Universities